Search Within

Alexander Noor Shoushtari

  1. "2018"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (7)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Melanoma Disease Management Team (18)
  4. Melanoma and Immunotherapeutics Service (18)
  5. Solid Tumor Oncology Division (18)
  6. GSK Faculty (8)

More Groups

People
  1. Paul Chapman (7)
  2. Jedd Wolchok (6)
  3. Michael Postow (6)
  4. Allison Betof Warner (5)
  5. Margaret Callahan (5)
  6. Katherine Panageas (4)

More People

Years
  1. 2018 (18)
Publications
  1. Journal of Clinical Oncology (10)
  2. American Journal of Surgical Pathology (1)
  3. Annals of Oncology (1)
  4. Annals of Surgical Oncology (1)
  5. Cancer Medicine (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (1)
  3. American Medical Association (1)
  4. Cell Press (1)
  5. Elsevier Inc. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of uveal melanoma with distant metastasis at initial staging: Impact of primary tumor therapy
    Meeting Abstract

    Modlin, L. A.; Kuriakose, R. K.; Francis, J. H.; Abramson, D. H.; Shoustari, A. N.; Barker, C. A.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Primary and metastatic melanoma with NTRK fusions
    Journal Article

    Lezcano, C.; Shoushtari, A. N.; Ariyan, C.; Hollmann, T. J.; Busam, K. J.
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A phase III, multicenter, randomized trial (SUMIT)
    Journal Article

    Carvajal, R. D.; Piperno-Neumann, S.; Kapiteijn, E.; Chapman, P. B.; Frank, S.; Joshua, A. M.; Piulats, J. M.; Wolter, P.; Cocquyt, V.; Chmielowski, B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • GNA11 Q209L mouse model reveals RasGRP3 as an essential signaling node in uveal melanoma
    Journal Article

    Moore, A. R.; Ran, L.; Guan, Y.; Sher, J. J.; Hitchman, T. D.; Zhang, J. Q.; Hwang, C.; Walzak, E. G.; Shoushtari, A. N.; Monette, S.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma
    Journal Article

    Shoushtari, A. N.; Friedman, C. F.; Navid-Azarbaijani, P.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Panageas, K. S.; Wolchok, J. D.; Chapman, P. B.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
    Journal Article

    Pollack, M. H.; Betof, A.; Dearden, H.; Rapazzo, K.; Valentine, I.; Brohl, A. S.; Ancell, K. K.; Long, G. V.; Menzies, A. M.; Eroglu, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save